It was a field day last week for health wonks in Washington. The CMS issued two major rules—one final, one proposed—that will shape how nearly half the nation's healthcare tab gets spent over the next decade.
New CDC data show white women on average lived slightly shorter lives in 2014 compared to 2013. Most experts agreed it was a worrisome harbinger of what awaits other groups suffering the ill-effects of our increasingly unequal society.
The skeptics were out in force last week when the CMS launched a major expansion of its comprehensive primary-care initiative. They are way off base.
State Medicaid agencies have launched a wide array of payment and care-delivery reforms, some of which go further than the federal government's efforts. While they offer the promise of delivering higher-quality care, it's unreasonable to expect them to deliver lower costs, at least in the short run.
Ever heard of the “therapeutic illusion”? I hadn't until I read a Perspective article in last week's New England Journal of Medicine that should be required reading for any healthcare executive serious about moving his or her organization from volume-driven to value-based care.
Need a job? In most American towns and cities, the best place to find new employment opportunities is in healthcare. But healthcare isn't an economic savior.
Two recent patient-safety initiatives—one designed to curb opioid overprescribing and the other a heart-device recall—reveal the limits of voluntary action when it comes to avoiding harm from drugs and medical devices.
Everyone is in favor of value-based reimbursement in healthcare, right? If you're still wearing those rose-colored glasses, take a closer look at last week's reaction to Medicare's proposal to test new ways of paying for drugs administered in physician offices and hospital outpatient departments.
Experimentation. Disruption. Innovation. The spirit of change was in the air at last week's Healthcare Information and Management Systems Society annual meeting in Las Vegas.
Texas' legislative effort to restrict abortion providers, to be reviewed this week by the U.S. Supreme Court in Whole Woman's Health v. Hellerstedt, has troubling economic implications for healthcare providers that go well beyond abortion. It's worth reviewing some of the issues raised by the case.
Though the nation still faces a shortage of primary-care physicians, regulatory and payment roadblocks to delivering that basic service in less expensive ways are finally starting to come down.
Employer-based health insurance isn't about to disappear. But its erosion will continue and could eventually reach a tipping point.